摘要
本文报告了42例中枢神经系统肿瘤的ER、PR状况。其中脑膜瘤10例,胶质瘤15例,神经纤维瘤8例,其他肿瘤9例。42例中,ER阳性者仅3例,占7.1％。PR阳性率:脑膜瘤组为60.0％,胶质瘤组为13.3％,神经纤维瘤组为37.5％,其他肿瘤组为11.1％。脑膜瘤PR含量明显高于胶质瘤、神经纤维瘤以及其他肿瘤。在脑膜瘤组,PR含量明显高于ER含量,提示脑膜瘤可能是孕激素的靶组织。神经纤维瘤组PR阳性率仅次于脑膜瘤,其PR含量也高于ER含量,与脑膜瘤类似。
Forty-two neoplasms of central nervous system (10 meningiomas, 15 gliomas, 8 nearofibromas and others 9) were evaluated by progeiterone and estrogen receptors, The incidence of estrogen receptor (ER) in the series was 7.1％ (3142) white the positive rate of progesterone receptor (PR)was 60.0％ in meningioma, 13.3％ in gliomas, 37.5％ in neurofibromas and 11.1％ in other tamers respectively The incidence of PR in neurofibromas was only Lower than that of meningiomas and meningioma like tumos, the value of PR was also higher than ER
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
1991年第3期129-132,共4页
Cancer Research on Prevention and Treatment
关键词
脑膜瘤
神经纤维瘤
受体
性激素
meningioma neurofibroma estrogen receptor progesterone receptor
